4-traders.com, stock quotes, stock exchange, market price, stock market advice, technical analysis, stock chart analysis, Company News
September 3, 2010 12:55 pm US/Eastern
Search
Dynamic quotes   
On
 | Off
  • Technical Analysis
  • Market Quotes
  • Market News
  • Market Screeners and Tools

4-Traders Homepage  >  Shares  >  Nasdaq  >  PONIARD PHARMACEUT   PARD   US7324493011

PONIARD PHARMACEUT (PARD)

  
Real time Streaming quotes -
Delayed Quote. Delayed Nasdaq - 09/03 12:38:13 pm
0.4695 USD   -0.11%
08/09PONIARD PHARMACEUT: Poniard Pharmaceuticals Reports Second Quarter 2010 Financi..
08/02PONIARD PHARMACEUT: Poniard Pharmaceuticals to Host Second Quarter 2010 Financi..
07/22PONIARD PHARMACEUT: Poniard Pharmaceuticals Receives NASDAQ Deficiency Notice R..
SummaryQuotesChart AnalysisNewsCalendarCompanyFundamentalsConsensus
NewsRSS News

PONIARD PHARMACEUT : Poniard Pharmaceuticals to Present at 12th Annual BIO CEO and Investor Conference

02/05/2010 | 09:30 am

SOUTH SAN FRANCISCO, Calif., Feb. 5 /PRNewswire-FirstCall/ -- Poniard Pharmaceuticals, Inc. (Nasdaq: PARD), a biopharmaceutical company focused on innovative oncology therapies, today announced that Ronald Martell, chief executive officer, will provide a corporate overview at the 12th Annual BIO CEO and Investor Conference on Tuesday, February 9, 2010 at 1:00 p.m. Eastern Time at the Waldorf-Astoria in New York City.

A live audio webcast of the corporate overview will be available for 10 business days on the "Events" page of the "News & Events" section of the Company's Web site at http://www.poniard.com.

About Poniard Pharmaceuticals

Poniard Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of innovative oncology products to impact the lives of people with cancer. For additional information please visit http://www.poniard.com.

(C) 2010 Poniard Pharmaceuticals, Inc. All Rights Reserved.

Poniard and Poniard Pharmaceuticals are trademarks of Poniard Pharmaceuticals, Inc.

SOURCE Poniard Pharmaceuticals, Inc.

Latest news on PONIARD PHARMACEUT
08/09Poniard Pharmaceuticals Reports Second Quarter 2010 Financial Results
08/02Poniard Pharmaceuticals to Host Second Quarter 2010 Financial Results Conference..
07/22Poniard Pharmaceuticals Receives NASDAQ Deficiency Notice Related to Minimum Bid..
05/03Poniard Pharmaceuticals to Host First Quarter 2010 Financial Results Conference ..
03/18U.S. Patent and Trademark Office Grants Reissue Patent on Picoplatin Composition..
03/15Poniard Pharmaceuticals Announces $6.3 Million Financing
03/01Poniard Pharmaceuticals to Host Fourth Quarter and Year End 2009 Financial Resul..
02/23Poniard Pharmaceuticals Secures $20 Million Committed Equity Financing Facility
02/05Poniard Pharmaceuticals to Present at 12th Annual BIO CEO and Investor Conferenc..
02/03Poniard Pharmaceuticals Announces Management Changes and Reduction in Force
Chart PONIARD PHARMACEUT
Short term
Mid-term
Long term
Graphique historique des cours de bourse de PONIARD PHARMACEUT
Full-screen chart
Income Statement Evolution
PONIARD PHARMACEUT : Income Statement Evolution
More Fundamentals
EPS Reviews
PONIARD PHARMACEUT : EPS Reviews
More Estimates Reviews
Price share PONIARD PHARMACEUT (USA), Source for Financial Market Quotes, Charts, Technical Analysis and Consensus. Stock market quotes including the latest stock price , stock market quote for the NASDAQ 100, news and fundamental investing data and price charts. The easy way to get information on stocks, currencies, indexes, commodities , certicates, and Warrants. Contact us ¤ Site map
Quotes are delayed 15 minutes for Nasdaq, Nyse and Euronext. Dow Jones indexes from Dow Jones & Company and Nasdaq indexes are 15 minutes delayed. CAC 40, Forex and Tradegate exchange are in real-time. Others exchanges are in end of day. Data are provided by Interactive Data - Tijd Beursmedia.
Copyright ©  2001 - 2010 Surperformance SAS /